Javier Narbona
5PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 28, 2026
GPA33-Targeted Trimeric Immunotoxin Exhibits Enhanced Antitumor Activity in Human Colorectal Cancer Xenografts.Javier Ruiz-de-la-Herrán, Javier Narbona, Rubén G Gordo
|Oct 16, 2025
An Innovative Immunotoxin Design Against Allergy Based on the IL-33 Cytokine and the Ribotoxin α-Sarcin.Javier Narbona, Rodrigo Lázaro-Gorines, Adrián Gutiérrez-Carmona
|Apr 16, 2024
Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses.Antonio Tapia-Galisteo, Iñigo Sánchez-Rodríguez, Javier Narbona
|Jul 29, 2023
Nanobody-Based EGFR-Targeting Immunotoxins for Colorectal Cancer Treatment.Javier Narbona, Luisa Hernández-Baraza, Rubén G Gordo
|Feb 25, 2023
A New Optimized Version of a Colorectal Cancer-Targeted Immunotoxin Based on a Non-Immunogenic Variant of the Ribotoxin α-Sarcin.Javier Narbona, Rubén G Gordo, Jaime Tomé-Amat
Pageof 1
Frequent Collaborators
5 joint publications
Javier Lacadena
3 joint publications
Rubén G Gordo
3 joint publications
Laura Sanz
1 joint publications
Jaime Tomé-Amat
1 joint publications
Luisa Hernández-Baraza
1 joint publications
Antonio Tapia-Galisteo
1 joint publications
Iñigo Sánchez-Rodríguez
1 joint publications
Patricia Iglesias-Hernández
1 joint publications
Anaïs Jiménez-Reinoso
1 joint publications
Marta Compte
